AcelRX drug device meets main goal of late-stage study; shares jump

by admin on May 21, 2013

(Reuters) – AcelRX Pharmaceuticals Inc said its experimental drug device to treat post-operative pain met the main goal of controlling pain in a late-stage study among patients who had undergone knee or hip replacement surgery. Shares of the company rose 31 percent to $8.44 in trading before the bell. The device showed that the drug showed a decrease in pain intensity as measured on a clinical …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: